These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31613925)

  • 1. Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis.
    Takei Y; Takahashi S; Nakasatomi M; Sakairi T; Ikeuchi H; Kaneko Y; Hiromura K; Nojima Y; Maeshima A
    PLoS One; 2019; 14(10):e0223703. PubMed ID: 31613925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury.
    Takahashi S; Nakasatomi M; Takei Y; Ikeuchi H; Sakairi T; Kaneko Y; Hiromura K; Nojima Y; Maeshima A
    Sci Rep; 2018 Mar; 8(1):5176. PubMed ID: 29581558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activin A: a novel urinary biomarker of renal impairment in multiple myeloma.
    Iriuchishima H; Maeshima A; Takahashi S; Ishizaki T; Yokohama A; Tsukamoto N; Saitoh T; Murakami H; Handa H
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31072919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of NOD2, NLRP3 and NLRC5 and renal injury in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Wang LY; Sun XJ; Chen M; Zhao MH
    J Transl Med; 2019 Jun; 17(1):197. PubMed ID: 31186034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
    Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study.
    Dekkema GJ; Abdulahad WH; Bijma T; Moran SM; Ryan L; Little MA; Stegeman CA; Heeringa P; Sanders JF
    Nephrol Dial Transplant; 2019 Feb; 34(2):234-242. PubMed ID: 29506265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological features of anti-neutrophil cytoplasmic antibody-associated vasculitis in patients with minor urinary abnormalities.
    Hasegawa J; Hoshino J; Sekine A; Hayami N; Suwabe T; Sumida K; Mise K; Ueno T; Yamanouchi M; Hazue R; Sawa N; Ohashi K; Fujii T; Takaichi K; Ubara Y
    Nephrology (Carlton); 2018 Nov; 23(11):1007-1012. PubMed ID: 28834647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary epidermal growth factor predicts renal prognosis in antineutrophil cytoplasmic antibody-associated vasculitis.
    Wu L; Li XQ; Goyal T; Eddy S; Kretzler M; Ju WJ; Chen M; Zhao MH
    Ann Rheum Dis; 2018 Sep; 77(9):1339-1344. PubMed ID: 29724728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis.
    Satrapova V; Sparding N; Genovese F; Karsdal MA; Bartonova L; Frausova D; Honsova E; Kollar M; Suchanek M; Koprivova H; Rysava R; Bednarova V; Tesar V; Hruskova Z
    Front Immunol; 2023; 14():1122972. PubMed ID: 37020541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary levels of high mobility group box-1 are associated with disease activity in antineutrophil cytoplasmic autoantibody-associated vasculitis.
    Ma TT; Wang H; Wang C; Chang DY; Zhao MH; Chen M
    PLoS One; 2015; 10(4):e0123586. PubMed ID: 25884225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Cheng L; Gou SJ; Qiu HY; Ma L; Fu P
    Clin Exp Immunol; 2018 Jan; 191(1):116-124. PubMed ID: 28940198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary mitochondrial DNA is a useful biomarker for assessing kidney injury of antineutrophil cytoplasmic antibody -associated vasculitis.
    Wu SJ; Yang X; Xu PC; Chen T; Gao S; Hu SY; Wei L; Yan TK
    Clin Chim Acta; 2020 Mar; 502():263-268. PubMed ID: 31758933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
    Kadiombo AT; Maeshima A; Kayakabe K; Ikeuchi H; Sakairi T; Kaneko Y; Hiromura K; Nojima Y
    Am J Physiol Renal Physiol; 2017 Feb; 312(2):F297-F304. PubMed ID: 27881396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for renal involvement in ANCA-associated vasculitis: room for improvement?
    Houben E; van der Heijden JW; van Dam B; Bax WA; Voskuyl AE; Penne EL
    Neth J Med; 2017 Jan; 75(1):21-26. PubMed ID: 28124664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
    Yuan J; Gou SJ; Huang J; Hao J; Chen M; Zhao MH
    Arthritis Res Ther; 2012 Jun; 14(3):R140. PubMed ID: 22691190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis.
    Moran SM; Scott J; Clarkson MR; Conlon N; Dunne J; Griffin MD; Griffin TP; Groarke E; Holian J; Judge C; Wyse J; McLoughlin K; O'Hara PV; Kretzler M; Little MA;
    J Am Soc Nephrol; 2021 Nov; 32(11):2920-2932. PubMed ID: 34518279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis.
    Manenti L; Vaglio A; Gnappi E; Maggiore U; Allegri L; Allinovi M; Urban ML; Delsante M; Galetti M; Nicastro M; Pilato FP; Buzio C
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2143-51. PubMed ID: 26542163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of urinary α1 microglobulin excretion is a useful marker of peritubular capillaritis in antineutrophil cytoplasmic antibody associated vasculitis.
    Ohashi N; Ishigaki S; Kitajima K; Tsuji N; Isobe S; Iwakura T; Ono M; Fujikura T; Tsuji T; Sakao Y; Kato A; Yasuda H
    Clin Exp Nephrol; 2015 Oct; 19(5):851-8. PubMed ID: 25528655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
    Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
    J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics combined with clinical analysis explores metabolic changes and potential serum metabolite biomarkers of antineutrophil cytoplasmic antibody-associated vasculitis with renal impairment.
    Liu S; Xu Q; Wang Y; Lv Y; Liu QQ
    PeerJ; 2023; 11():e15051. PubMed ID: 36942002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.